- 全部删除
您的购物车当前为空
Loxapine succinate (Loxapac) 是D2/D4多巴胺受体,5-羟色胺受体抑制剂,用于精神分裂症。

Loxapine succinate (Loxapac) 是D2/D4多巴胺受体,5-羟色胺受体抑制剂,用于精神分裂症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 279 | In stock | |
| 50 mg | ¥ 398 | In stock | |
| 100 mg | ¥ 578 | In stock | |
| 200 mg | ¥ 933 | In stock | |
| 500 mg | ¥ 1,990 | 5日内发货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 638 | In stock |
Loxapine succinate 相关产品
| 产品描述 | Loxapine succinate (Loxapac), a D2DR and D4DR inhibitor, is utilized in schizophrenia. |
| 靶点活性 | D4 receptor (human):7.5 nM(Ki), D2 receptor (human):24 nM(Ki), 5-HT2 (human):6.2 nM(Ki), 5-HT2 (bovine):6.6 nM(Ki), 5-HT2 (bovine):6.8 nM(Ki) |
| 体外活性 | 在大鼠中,皮下注射Loxapine(0.3 mg/kg)能够引起全身僵硬.在大鼠脑部,给药Loxapine(5 mg/kg)不能够改变多巴胺受体密度,但是会降低血清素受体密度. |
| 体内活性 | 在人脑额叶皮层(ki=6.2 nM)和牛脑额叶皮层(ki=6.6 nM)中,Loxapine能够使[3H]酮色林与5-HT2受体结合。在LPS-活化的混合胶质细胞中,Loxapine(0.2 μM,2 μM和20 μM)能够减少IL-1β和IL-2分泌。 |
| 别名 | 琥珀酸洛沙平, 丁二酸洛沙平, Loxapine succinate salt, Loxapac, Daxolin, Cloxazepin |
| 分子量 | 445.9 |
| 分子式 | C22H24ClN3O5 |
| CAS No. | 27833-64-3 |
| Smiles | OC(=O)CCC(=O)O.CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 2 mg/mL (4.49 mM), Sonication is recommended. DMSO: 82 mg/mL (183.9 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容